FPI: The company's life sciences business segment and semiconductor-related business are progressing in an orderly manner
On September 22, FPI stated on the interactive platform that the company's life sciences business segment and semiconductor-related business are progressing in an orderly manner, currently accounting for a small proportion of the company's overall business
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments